M. Nebrig

Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis

W. Weichert, R. Somasundaram, D. Seehofer, 2012, Clinical transplantation.

PARP-1 expression as a prognostic factor in Desmoid-type fibromatosis.

C. Denkert, J. Budczies, P. Wust, 2019, Annals of diagnostic pathology.

ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment

C. Higgins, K. Weylandt, A. Sardini, 2007, Molecular Cancer Therapeutics.

Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma

J. Pratschke, F. Klein, M. Bahra, 2019, BMC Surgery.

Symptomatic lymphoceles after kidney transplantation – multivariate analysis of risk factors and outcome after laparoscopic fenestration

P. Reinke, A. Pascher, S. Tullius, 2010, Clinical transplantation.

Advances in the management of the explanted donor liver

P. Neuhaus, A. Pascher, M. Nebrig, 2014, Nature Reviews Gastroenterology &Hepatology.

Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis.

P. Neuhaus, A. Pascher, M. Nebrig, 2013, Deutsches Arzteblatt international.

Irreversible Liver Failure: Treatment by Transplantation

P. Neuhaus, A. Pascher, M. Nebrig, 2013 .

Treatment, outcome and quality of life after Fournier's gangrene: a multicentre study

D. Seehofer, H. Bruch, O. Guckelberger, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Article on CIC-3 and cancer drug resistance

K. Weylandt, D. Carmena, M. Nebrig, 2008, Molecular Cancer Therapeutics.